Please login to the form below

Not currently logged in
Email:
Password:

solanezumab

This page shows the latest solanezumab news and features for those working in and with pharma, biotech and healthcare.

Roche engaged in talks with FDA for Alzheimer’s drug candidate

Roche engaged in talks with FDA for Alzheimer’s drug candidate

In the DIAN-TU-001 trial, researchers from the Dominantly Inherited Alzheimer Network-Trials Unit (DIAN-TU) evaluated two investigational anti-amyloid antibodies – gantenerumab or Lilly’s solanezumab – versus placebo in

Latest news

More from news
Approximately 5 fully matching, plus 39 partially matching documents found.

Latest Intelligence

  • Holding on to hope for Alzheimer’s advances Holding on to hope for Alzheimer’s advances

    Lilly said that while the study results, ‘including many secondary clinical endpoints, directionally favoured solanezumab, the magnitudes of treatment differences were small’. ... December, where Lilly confirmed it will not pursue regulatory

  • Interview: Mike Hutton, Lilly Interview: Mike Hutton, Lilly

    Lilly's great hope in amyloid beta is now solanezumab, a candidate with a chequered history. ... But Lilly is pressing on with a third late-stage trial, and Dr Hutton was adamant solanezumab remains a priority project for Lilly.

More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Sustainability
Environment: where does the pharmaceutical industry stand?
...
The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...